These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6283060)

  • 1. Evidence that the discriminative stimulus properties of fentanyl and ethylketocyclazocine are mediated by an interaction with different opiate receptors.
    Shearman GT; Herz A
    J Pharmacol Exp Ther; 1982 Jun; 221(3):735-9. PubMed ID: 6283060
    [No Abstract]   [Full Text] [Related]  

  • 2. D-Ala2,D-Leu5-enkephalin generalizes to a discriminative stimulus produced by fentanyl but not ethylketocyclazocine.
    Shearman GT; Herz A
    Pharmacol Biochem Behav; 1982 Feb; 16(2):249-52. PubMed ID: 6280202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists.
    Shearman GT; Herz A
    Psychopharmacology (Berl); 1982; 78(1):63-6. PubMed ID: 6292982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus properties of bremazocine in the rat.
    Shearman GT; Herz A
    Neuropharmacology; 1981 Dec; 20(12A):1209-13. PubMed ID: 7322297
    [No Abstract]   [Full Text] [Related]  

  • 8. An in vivo pharmacological analysis of benzomorphan binding sites in rats.
    Cowan A; Gmerek DE
    NIDA Res Monogr; 1984 Mar; 49():114-20. PubMed ID: 6090914
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of kappa agonists and dexoxadrol on the acquisition of conditional discriminations in monkeys.
    Moerschbaecher JM; Brocklehurst C; Devia C; Faust WB
    J Pharmacol Exp Ther; 1987 Nov; 243(2):737-44. PubMed ID: 2824758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat.
    Shearman GT; Herz A
    Eur J Pharmacol; 1982 Aug; 82(3-4):167-72. PubMed ID: 6290235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence for benzomorphan-selective receptors in rats.
    Gmerek DE; Cowan A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):110-5. PubMed ID: 6146703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.
    White JM; Holtzman SG
    J Pharmacol Exp Ther; 1983 Jan; 224(1):95-9. PubMed ID: 6336785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mu- and kappa-opioid receptor agonists on urinary output in mice.
    Rathbun RC; Kattau RW; Leander JD
    Pharmacol Biochem Behav; 1983 Nov; 19(5):863-6. PubMed ID: 6316374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid- and phencyclidine-like discriminative effects of ditolylguanidine, a selective sigma ligand.
    Holtzman SG
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1054-62. PubMed ID: 2539453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac slowing induced by peripheral kappa-opiate receptor stimulation in rats.
    Gautret B; Schmitt H
    Eur J Pharmacol; 1984 Jun; 102(1):159-63. PubMed ID: 6148245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus effects of prototype opiate receptor agonists in monkeys.
    Teal JJ; Holtzman SG
    Eur J Pharmacol; 1980 Nov; 68(1):1-10. PubMed ID: 6256182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bremazocine: a potent, long-acting opiate kappa-agonist.
    Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
    Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
    [No Abstract]   [Full Text] [Related]  

  • 20. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.